Edition:
United Kingdom

Inflarx NV (IFRX.OQ)

IFRX.OQ on NASDAQ Stock Exchange Global Select Market

39.27USD
25 Apr 2018
Change (% chg)

$1.18 (+3.10%)
Prev Close
$38.09
Open
$38.05
Day's High
$39.45
Day's Low
$38.02
Volume
3,192
Avg. Vol
14,358
52-wk High
$39.50
52-wk Low
$14.50

Select another date:

Thu, Mar 8 2018

BRIEF-Inflarx Announces First Patient Enrolled In Phase Iib Trial With Lead Candidate Ifx-1 In Hidradenitis Suppurativa

* INFLARX ANNOUNCES FIRST PATIENT ENROLLED IN PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA Source text for Eikon: Further company coverage:

BRIEF-Inflarx Receives IND Acceptance To Proceed With A Phase IIB Trial With Lead Candidate IFX-1 In Hidradenitis Suppurativa

* INFLARX RECEIVES IND ACCEPTANCE TO PROCEED WITH A PHASE IIB TRIAL WITH LEAD CANDIDATE IFX-1 IN HIDRADENITIS SUPPURATIVA

BRIEF-Ra Capital Management Reports 12.3 Pct Passive Stake In Inflarx Nv

* RA CAPITAL MANAGEMENT LLC REPORTS 12.3 PERCENT PASSIVE STAKE IN INFLARX NV AS OF NOVEMBER 8 - SEC FILING Source text: [http://bit.ly/2kmho2j] Further company coverage:

Select another date: